Similar articles

• Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices.

  Khamees RE, Kishk EA, Mahmoud SS, Said ME, Taha OT. Khamees RE, et al. Eur J Contracept Reprod Health Care. 2022 Feb;27(1):23-27. doi: 10.1080/13625187.2021.1991303. Epub 2021 Oct 27. Eur J Contracept Reprod Health Care. 2022. Retraction in: Eur J Contracept Reprod Health Care. 2022 Oct;27(5):436. doi: 10.1080/13625187.2022.2116835. PMID: 34704516 Retracted. Clinical Trial.
• [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].

  Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C. Imperato F, et al. Minerva Ginecol. 2002 Jun;54(3):271-8. Minerva Ginecol. 2002. PMID: 12063443 Italian.
• Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study.

  Gatz JL, Armstrong MA, Postlethwaite D, Raine-Bennett T, Chillemi G, Alabaster A, Merchant M, Reed SD, Ichikawa L, Getahun D, Fassett MJ, Shi JM, Xie F, Chiu VY, Im TM, Takhar HS, Wang J, Saltus CW, Ritchey ME, Asiimwe A, Pisa F, Schoendorf J, Wahdan Y, Zhou X, Hunter S, Anthony MS, Peipert JF. Gatz JL, et al. Am J Obstet Gynecol. 2022 Jul;227(1):57.e1-57.e13. doi: 10.1016/j.ajog.2022.03.062. Epub 2022 Apr 5. Am J Obstet Gynecol. 2022. PMID: 35395215
• A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

  Sturridge F, Guillebaud J. Sturridge F, et al. Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006. Drug Saf. 1996. PMID: 8968696 Review.
• Endometrial morphological changes in IUD users: a review.

  Sheppard BL. Sheppard BL. Contraception. 1987 Jul;36(1):1-10. doi: 10.1016/0010-7824(87)90057-6. Contraception. 1987. PMID: 3117492 Review.